510(k) Report

510(k) · Cleared

Cleared

U2 Hip Stem, TI Plasma Spray

K062978510(k) TraditionalCleared Jan 16, 2007109-day reviewClass II21 CFR 888.3360

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

United Orthopedic Corp. · LWJ Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Uncemented

Cleared on Jan 16, 2007 as substantially equivalent to K000760 (Biomet, Inc., 2000) and 1 other predicate after a 109-day review. Its family tree reaches back 1 generation to 2000. 1 later device descends from it.

Decided
Jan 16, 2007
Review
109 days
Class
Class II
Product code
LWJ
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K000760 (2000). 2 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor2013: 1 descendant clearedK000760 · Reach Femoral Component · Biomet, Inc. · 2000200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K000760 · Reach Femoral Component · Biomet, Inc. · 20000
  1. Root · 1 generation backK000760 Reach Femoral ComponentBiomet, Inc. · 2000
  2. This deviceK062978 U2 Hip Stem, TI Plasma SprayUnited Orthopedic Corp. · 2007
  3. Descendant · cites it directly · 0 of its ownK130149 U2 Hip System, Expanded Indications for UseUnited Orthopedic Corporation · 2013

Most influential descendants

Showing 1 of 1 · See all
  • K130149U2 Hip System, Expanded Indications for UseUnited Orthopedic Corporation · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K000760Reach Femoral ComponentBiomet, Inc.2000—
0 (this device)K062978U2 Hip Stem, TI Plasma SprayUnited Orthopedic Corp.2007—
+1K130149U2 Hip System, Expanded Indications for UseUnited Orthopedic Corporation2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201310
FIG. 1 — Lineage of K062978, 2000–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K000760Reach Femoral Component
Summary page 1
…Name: Hip joint femoral (hemi-hip) metallic cemented or unceemented prosthesis (888.3360) Predicate Device: Reach 1 Hip Stem, Ti plasma spray (K000760) United U2 HA/Ti Plasma Spray (K003237) Device Description: The U2 Hip Stem, Ti plasma spray is composed…
Biomet, Inc.2000—
*K003237U2 Hip Stem, TI Porous Coated
Summary page 1
…emented prosthesis (888.3360) Predicate Device: Reach 1 Hip Stem, Ti plasma spray (K000760) United U2 HA/Ti Plasma Spray (K003237) Device Description: The U2 Hip Stem, Ti plasma spray is composed of a metallic femoral stem, which is designed to articulate w…
United Orthopedic Corp.2001—

Also cleared against K000760: 4 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K130149U2 Hip System, Expanded Indications for UseUnited Orthopedic Corporation20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K130149 (United Orthopedic Corporation, 2013) has gone furthest, with 0 descendants of its own.
  • 4 other devices also cite its predicate K000760.

How does its category compare?

All LWJ devices

LWJ Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LWJ

1in 2012

2007: 22008: 12009: 12011: 12012: 1
2007high 2 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LWJ

Too few LWJ 510(k)s in any year since 2007 to give a median.

Recalls per year · LWJ

2in 2023

2007: 102008: 22009: 22013: 12023: 2
2007high 10 (2007) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LWJ

51in 2025

2007: 682008: 722009: 842010: 1322011: 2552012: 3902013: 5222014: 4522015: 3102016: 2932017: 3112018: 2272019: 2102020: 1892021: 1552022: 912023: 722024: 542025: 51
2007high 522 (2013) · low 51 (2025)2025

MAUDE reports naming product code LWJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—1068
20081—272
20091—284
20100—0132
20111—0255
20121—0390
20130—1522
20140—0452
20150—0310
20160—0293
20170—0311
20180—0227
20190—0210
20200—0189
20210—0155
20220—091
20230—272
20240—054
20250—051
20260—0—

What is it indicated for?

This device is indicated in hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: Non-inflammatory degenerative joint disease such as osteoathritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia; Inflammatory degenerative joint disease such as rheumatoid arthritis; Correction of function deformity; Revision procedures where other…

Read the full statement (97 words)

This device is indicated in hip arthroplasty for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions:

Non-inflammatory degenerative joint disease such as osteoathritis, avascular necrosis, ankylosis, protrusio acetabuli, and painful hip dysplasia;

Inflammatory degenerative joint disease such as rheumatoid arthritis;

Correction of function deformity;

Revision procedures where other treatments or devices have failed; and

Treatment of nonunion, femoral neck, and trochanteric fractures of the proximal femur with head involvement that are unmanageable using other techniques.

This device is a single use implant and intended for cementless use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062978: U2 Hip Stem, TI Plasma Spray.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062978

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026